Targeted Knockdown of Hepatic △-5 Fatty Acid Desaturase FADS1 Aggravates Atherosclerosis in ApoE-/- Mice

被引:0
|
作者
Liu, Qiulei [1 ]
Wang, Peng [1 ]
Yang, Zhao [2 ]
Dai, Yue [2 ]
Wang, Sheng [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Vasc Surg, Beijing 100029, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2024年 / 29卷 / 04期
关键词
triangle-5 fatty acid desaturase; atherosclerosis; antisense oligonucleotides; angiopoietin-like; 4; ARACHIDONIC-ACID; POLYMORPHISMS; METASTASIS; DEFICIENT; ANGPTL4; IMPACT; MODEL; FLOW;
D O I
10.31083/j.fbl2904131
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The endogenous metabolism of polyunsaturated fatty acids is regulated by the fatty acid desaturase (FADS) gene cluster and is strongly associated with diseases such as atherosclerosis, dyslipidemia, and type 2 diabetes. However, the association between FADS and atherosclerosis remains a subject of debate. Methods: In this study, we specifically investigated the physiological role of triangle-5 fatty acid desaturase (FADS1) in aortic and peripheral vessel (namely, the femoral artery) atherosclerosis by targeting the selective of hepatic Fads1 in ApoE-/- mice exacerbated aortic atherosclerosis and non-alcoholic fatty liver disease (NAFLD), resulting in weight loss. Upregulation of FADS1 mRNA expression in more severe atherosclerosis vascular tissues potentially caused the upregulation of angiopoietin-like 4 expression. Conclusions: Our study demonstrated that knockdown of hepatic Fads1 in ApoE-/- mice aggravates spontaneous atherosclerosis and NAFLD but does not affect peripheral atherosclerosis (femoral artery) induced by vascular cuff combined with tandem stenosis.
引用
收藏
页数:15
相关论文
共 36 条
  • [31] A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
    Takagahara, Shuichi
    Shinohara, Hiromi
    Itokawa, Shigekazu
    Satomi, Yoshinori
    Ando, Ayumi
    Yamamoto, Takeshi
    Suzuki, Hideo
    Fujimoto, Takuya
    Kubo, Kazuki
    Ikeda, Shota
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 371 (02): : 290 - 298
  • [32] MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice
    Yin, Ruihua
    Zhu, Xiaoyan
    Wang, Jing
    Yang, Shaonan
    Ma, Aijun
    Xiao, Qi
    Song, Jinyang
    Pan, Xudong
    ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (05) : 676 - 689
  • [33] Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice
    Zhou, Enchen
    Li, Zhuang
    Nakashima, Hiroyuki
    Liu, Cong
    Ying, Zhixiong
    Foks, Amanda C.
    Berbee, Jimmy F. P.
    van Dijk, Ko Willems
    Rensen, Patrick C. N.
    Wang, Yanan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (04) : 1474 - 1486
  • [34] Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE-/- mice
    Yu, Xichao
    Ding, Xue
    Feng, Han
    Bi, Yunhui
    Li, Yu
    Shan, Jinjun
    Bian, Huimin
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [35] Combined deficiency of fatty acid-binding proteins aP2 and mal1 lowers serum cholesterol and triglycerides and reduces atherosclerosis in apoE-deficient mice
    Boord, JB
    Maeda, K
    Babaev, VR
    Makowski, L
    Zhang, YM
    Gorgun, ZC
    Fazio, S
    Hotamisligil, GS
    Linton, MF
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A60 - A60
  • [36] Exendin-4, a glucagon-like peptide-1 receptor agonist, modulates hepatic fatty acid composition and Δ-5-desaturase index in a murine model of non-alcoholic steatohepatitis
    Kawaguchi, Takumi
    Itou, Minoru
    Taniguchi, Eitaro
    Sata, Michio
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 (03) : 782 - 787